Our data show that CYLD is strongly expressed in the dermal macrophages and monocyte-derived macrophages (MDMs) of AD patients and that CYLD impairs STAT1- and NF-κB-dependent control of S. aureus in macrophages. This evidence concerns the gene STAT1 and Alzheimer disease.